𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

✍ Scribed by Furuhashi, Masato; Tuncman, Gürol; Görgün, Cem Z.; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.

Book ID
109896700
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
782 KB
Volume
447
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M. Furuhashi, G. Tuncman, C.Z. Görgün, L
M. Furuhashi, G. Tuncman, C.Z. Görgün, L. Makowski, G. Atsumi, E. Vaillancourt, K. Kono, V.R. Babaev, S. Fazio, M.F. Linton, R. Sulsky, J.A. Robl, R.A. Parker, G.S. Hotamisligil, ,Tratamiento de la diabetes y la ateroesclerosis mediante la inhibición de la proteína de unión a ácidos grasos aP2 Treatment of diabetes and atherosclerosis by inhibiting fatty acid binding protein aP2 Nature 447 (2007) 959 965.
✍ Marta Alegret 📂 Article 📅 2007 🏛 Elsevier Science 🌐 Spanish ⚖ 54 KB
Type 2 diabetes-associated fatty acid bi
Type 2 diabetes-associated fatty acid binding protein 2 promoter haplotypes are differentially regulated by GATA factors
✍ Maja Klapper; Mike Böhme; Inke Nitz; Frank Döring 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

## Communicated by Ju ¨rgen Horst The human intestinal fatty acid binding protein 2 (FABP2) mediates fat absorption by binding and intracellular trafficking of long-chain free fatty acids. Studies with knockout mice and association analysis of polymorphisms revealed that FABP2 is a susceptibility